Dynamic Advisor Solutions LLC Reduces Stock Position in ARK Genomic Revolution ETF (BATS:ARKG)

Dynamic Advisor Solutions LLC cut its stake in ARK Genomic Revolution ETF (BATS:ARKGFree Report) by 8.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 12,390 shares of the company’s stock after selling 1,200 shares during the period. Dynamic Advisor Solutions LLC’s holdings in ARK Genomic Revolution ETF were worth $292,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. increased its position in ARK Genomic Revolution ETF by 31.0% during the third quarter. JPMorgan Chase & Co. now owns 2,955,279 shares of the company’s stock valued at $75,655,000 after acquiring an additional 698,701 shares during the last quarter. Barclays PLC increased its position in shares of ARK Genomic Revolution ETF by 252.7% during the 3rd quarter. Barclays PLC now owns 285,108 shares of the company’s stock valued at $7,299,000 after purchasing an additional 204,283 shares during the last quarter. PFM Health Sciences LP bought a new position in shares of ARK Genomic Revolution ETF in the 3rd quarter worth approximately $2,226,000. Quadrature Capital Ltd purchased a new position in shares of ARK Genomic Revolution ETF in the third quarter worth approximately $1,970,000. Finally, Tallon Kerry Patrick bought a new stake in ARK Genomic Revolution ETF during the fourth quarter valued at approximately $637,000.

ARK Genomic Revolution ETF Stock Up 12.8 %

Shares of ARKG stock opened at $26.63 on Wednesday. The company’s 50-day simple moving average is $25.04 and its two-hundred day simple moving average is $25.17.

ARK Genomic Revolution ETF Profile

(Free Report)

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

Featured Articles

Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKGFree Report).

Institutional Ownership by Quarter for ARK Genomic Revolution ETF (BATS:ARKG)

Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.